Michelle Kim, MD
Surgery · Boston, MANPI 1609213867
Payments from drug & device makers
Across 33 payments — averaging $267.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gyrus ACMI, Inc.$4K
- Civco Medical Instruments$1K
- Boston Scientific$1K
- Procept Biorobotics Corporation$554
- Medtronic$381
- Intuitive Surgical$372
- plus $658 from 6 others
What the payments were for
- Consulting fees$5,02957%
- Travel & lodging$2,52529%
- Food & beverage$1,26914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gyrus ACMI, Inc. | 4 | $4,325 |
| Civco Medical Instruments | 2 | $1,334 |
| Boston Scientific | 3 | $1,200 |
| Procept Biorobotics Corporation | 5 | $554 |
| Medtronic | 8 | $381 |
| Intuitive Surgical | 1 | $372 |
| Paragonix Technologies, Inc. | 1 | $190 |
| AbbVie(2 entities) | 3 | $169 |
| Johnson & Johnson | 1 | $153 |
| Zimvie Inc. | 3 | $98 |
| Portola Pharmaceuticals, LLC | 1 | $26 |
| Photocure Inc | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Soltive$2,750
- MEDICAL CONTROL UNIT FOR ENDOSURGERY UCES-4$1,575
- GENERAL BPH$1,200
- AquaBeam Robotic System$445
- Da Vinci Surgical System$372
- Erleada$153
- BOTOX$119
How this compares
$8,823 in reported general payments places this provider in the 75th percentile of 694 surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 42 | $31,148 |
| GemtesaVibegron | 18 | $17,762 |
| Trospium Chloride ErTrospium Chloride | 19 | $2,543 |
| Estradiol | 31 | $1,988 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 65 | $1,404 |
| Methenamine Hippurate | 22 | $948 |
| Tamsulosin Hcl | 28 | $330 |
| Tadalafil | 14 | $242 |
| Finasteride | 33 | $225 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other surgery in Boston
- Monica BertagnolliBoston$155.3M
- Stephen MillerBoston$3.7M
- Michael TarnoffBoston$1.4M
- Omar KudsiBoston$991K
- Allan GoldsteinBoston$501K
- Chad WilsonBoston$363K
- Ankit MehtaBoston$307K
- Richard HodinBoston$284K
- Nahel EliasBoston$219K
- Ali TavakkolizadehBoston$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.